News

< Back

AFAR and the McKnight Brain Research Foundation (MBRF) are pleased to announce the renewal of the grant award program, The McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss

AFAR and the McKnight Brain Research Foundation (MBRF) are pleased to announce the renewal of the grant award program, The McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss

AFAR and the McKnight Brain Research Foundation (MBRF) are pleased to announce the renewal of the grant award program, The McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss.

The Innovator Awards program was launched in 2021 with a $4,615,000 grant from the MBRF to AFAR. The successful program has supported six investigators to date, who have each received three-year awards of $750,000. This year, the MBRF renewed its commitment with a $4,626,500 award to AFAR to expand the network of investigators who focus their research on cognitive aging and memory loss.

Each year, MBRF and AFAR will provide up to two three-year awards of $750,000. One award will be made to support studies focusing on clinical translational research and another award will support studies understanding basic biological mechanisms underlying cognitive aging and age-related memory loss. The award targets full-time independent investigators at the rank of Assistant Professor or Associate Professor (or equivalent) who have already demonstrated a firm commitment to cognitive aging research.

The Innovator Awards are reviewed by an esteemed committee of leaders in cognitive aging research. The committee’s recommendations will be presented to MBRF and AFAR for final funding decisions. AFAR anticipates awarding the next two recipients in September 2024. Applications are due August 12, 2024

Read research profiles on the past recipients here: 2023, 2022, and 2021.

Read our Grantee Spotlight Interviews with the 2023 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss here.

Read a related press release here.

More Recent News

View All News >
AFAR in the News: FAST Biomarkers Initiative advances as part of federal ARPA-H’s PROSPR Program
AFAR in the News: FAST Biomarkers Initiative advances as part of federal ARPA-H’s PROSPR Program
AFAR News: Michael Bass and Shelley Diamond elected to Board of Directors
AFAR News: Michael Bass and Shelley Diamond elected to Board of Directors
AFAR Expert in the News: Scholar-in-Residence Raiany Romanni-Klein, PhD, discusses socioeconomic impact of extending healthspan on the Aging Well Podcast
AFAR Expert in the News: Scholar-in-Residence Raiany Romanni-Klein, PhD, discusses socioeconomic impact of extending healthspan on the Aging Well Podcast
AFAR Experts in the News: Scientific Director Steven N. Austad, PhD, and grantee Vera Gorbudova, PhD, on Long-Living Animals in The Washington Post
AFAR Experts in the News: Scientific Director Steven N. Austad, PhD, and grantee Vera Gorbudova, PhD, on Long-Living Animals in The Washington Post
AFAR Grantees in the News: New research co-authored by Grantees Andrea Francesca Salvador, PhD, and Christoph Thaiss, PhD, on the possible gut–brain connection driving age-related memory loss published in Nature
AFAR Grantees in the News: New research co-authored by Grantees Andrea Francesca Salvador, PhD, and Christoph Thaiss, PhD, on the possible gut–brain connection driving age-related memory loss published in Nature
Los Angeles Times spotlights the Field of Geroscience
Los Angeles Times spotlights the Field of Geroscience
In Memoriam: Richard Menschel
In Memoriam: Richard Menschel
AFAR Leadership in the News: Scientific Director Steven N. Austad, PhD, featured on The Dan Buettner Podcast
AFAR Leadership in the News: Scientific Director Steven N. Austad, PhD, featured on The Dan Buettner Podcast
AFAR Board Members in the News: Nir Barzilai, MD, and Mark Lachs, MD, on therapeutics to extend healthspan in Men’s Health feature on longevity tech
AFAR Board Members in the News: Nir Barzilai, MD, and Mark Lachs, MD, on therapeutics to extend healthspan in Men’s Health feature on longevity tech